Design of a FAIR digital data health infrastructure in Africa for COVID-19 reporting and research.
data science
ethical
health information
knowledge capture
legal and social implications
medical informatics
population genetics
social health care
viral genomes
Journal
Advanced genetics (Hoboken, N.J.)
ISSN: 2641-6573
Titre abrégé: Adv Genet (Hoboken)
Pays: United States
ID NLM: 101774320
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
30
03
2021
revised:
20
05
2021
accepted:
21
05
2021
entrez:
13
9
2021
pubmed:
14
9
2021
medline:
14
9
2021
Statut:
ppublish
Résumé
The limited volume of COVID-19 data from Africa raises concerns for global genome research, which requires a diversity of genotypes for accurate disease prediction, including on the provenance of the new SARS-CoV-2 mutations. The Virus Outbreak Data Network (VODAN)-Africa studied the possibility of increasing the production of clinical data, finding concerns about data ownership, and the limited use of health data for quality treatment at point of care. To address this, VODAN Africa developed an architecture to record clinical health data and research data collected on the incidence of COVID-19, producing these as human- and machine-readable data objects in a distributed architecture of locally governed, linked, human- and machine-readable data. This architecture supports analytics at the point of care and-through data visiting, across facilities-for generic analytics. An algorithm was run across FAIR Data Points to visit the distributed data and produce aggregate findings. The FAIR data architecture is deployed in Uganda, Ethiopia, Liberia, Nigeria, Kenya, Somalia, Tanzania, Zimbabwe, and Tunisia.
Identifiants
pubmed: 34514430
doi: 10.1002/ggn2.10050
pii: GGN210050
pmc: PMC8420285
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e10050Informations de copyright
© 2021 The Authors. Advanced Genetics published by Wiley Periodicals LLC.
Déclaration de conflit d'intérêts
All authors declare they have no competing interests.
Références
Nature. 2021 Feb;590(7847):542
pubmed: 33597774
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
Lancet Digit Health. 2020 Apr;2(4):e160-e162
pubmed: 33328076
Lancet Microbe. 2020 Oct;1(6):e227-e228
pubmed: 32838350
Cell. 2019 Mar 21;177(1):26-31
pubmed: 30901543
Digit Health. 2016 Nov 24;2:2055207616679264
pubmed: 29942576
Lancet Glob Health. 2020 Nov;8(11):e1361-e1363
pubmed: 32791118
EClinicalMedicine. 2020 Dec;29:100630
pubmed: 33200120
Lancet Infect Dis. 2021 Sep;21(9):e281-e289
pubmed: 33587898
Lancet Digit Health. 2021 Apr;3(4):e213-e216
pubmed: 33610488
Radiother Oncol. 2016 Dec;121(3):459-467
pubmed: 28029405
Science. 2020 Aug 7;369(6504):624-626
pubmed: 32764055
Glob Health Epidemiol Genom. 2018 Jun 8;3:e12
pubmed: 30263136